Kato, H., Miyakawa, Y., Hidaka, Y., Inoue, N., Ito, S., Kagami, S., . . . Okada, H. (2018). Safety and effectiveness of eculizumab for adult patients with atypical hemolytic–uremic syndrome in Japan: Interim analysis of post-marketing surveillance. Clin Exp Nephrol.
Citación estilo ChicagoKato, Hideki, et al. "Safety and Effectiveness of Eculizumab for Adult Patients With Atypical Hemolytic–uremic Syndrome in Japan: Interim Analysis of Post-marketing Surveillance." Clin Exp Nephrol 2018.
Cita MLAKato, Hideki, et al. "Safety and Effectiveness of Eculizumab for Adult Patients With Atypical Hemolytic–uremic Syndrome in Japan: Interim Analysis of Post-marketing Surveillance." Clin Exp Nephrol 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.